Clinical Trials Browser

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Disease Progression

Colorectal Neoplasms

Colorectal Cancer, Hereditary Nonpolyposis, Type 6, Carcinoma, Colorectal Neoplasms

Squamous Cell Carcinoma of Head and Neck, Neoplasms, Squamous Cell

Colorectal Neoplasms

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Glioblastoma, Oligodendroglioma

Colorectal Neoplasms

Colorectal Cancer Metastatic

Colonic Neoplasms, Colorectal Neoplasms

Colorectal Cancer Metastatic

Head and Neck Neoplasms

Squamous Cell Carcinoma of Head and Neck

Carcinoma, Non-Small-Cell Lung

Colorectal Cancer Metastatic

Colorectal Neoplasms

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Glioblastoma, Glioma, Oligodendroglioma

Carcinoma, Squamous Cell, Head and Neck Neoplasms

Squamous Cell Carcinoma of Head and Neck, Salivary Gland Neoplasms, Tongue Neoplasms

Pancreatic Neoplasms

Colorectal Neoplasms

Squamous Cell Carcinoma of Head and Neck

Squamous Cell Carcinoma of Head and Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Tongue Neoplasms

Brain Neoplasms, Glioma

Breast Neoplasms, Esophageal Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Pancreatic Neoplasms

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Neoplasms

Head and Neck Neoplasms

Colonic Neoplasms, Rectal Neoplasms

Carcinoma, Squamous Cell, Head and Neck Neoplasms

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Carcinoma, Adenosquamous

Carcinoma, Carcinoma, Squamous Cell, Oropharyngeal Neoplasms

Rectal Neoplasms

Head and Neck Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Colorectal Neoplasms

Carcinoma, Non-Small-Cell Lung

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Pancreatic Neoplasms

Colorectal Neoplasms

Adenocarcinoma of Lung, Adenocarcinoma, Lung Neoplasms

Neoplasms, Squamous Cell

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Nasopharyngeal Carcinoma

Carcinoma, Adenoid Cystic

Stomach Neoplasms

Clinical Trials

Encorafenib, Cetuximab, and Nivolumab in Treating Patients With Microsatellite Stable, BRAFV600E Mutated Unresectable or Metastatic Colorectal Cancer

A Study of VS-6766 and Cetuximab in Patients With Advanced Colorectal Cancer

Dual Administration Of Intraperitoneal And Intravenous TROP2-Directed CAR-NK With TGF-Beta Receptor 2 (TGFBR2) Knock Out (KO) Therapy For Colorectal Cancer-Related Peritoneal Carcinomatosis: A Phase 1/2 Trial ("Chip-CRC Trial")

Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma

A Multicenter Phase 1b/2 Study of Adagrasib, Cetuximab, and Cemiplimab for Metastatic Colorectal Cancer Harboring KRAS G12C Mutations

LY3214996 and Cetuximab Alone or in Combination With Abemaciclib for the Treatment of Unresectable or Metastatic Colorectal Cancer

Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age

The Phase 1b/IIa, Open-label, Dose Escalation and Dose Expansion to Evaluate Safety, Tolerability, and Preliminary Efficacy of the Combination of HCB101, Cetuximab/Bevacizumab, and FOLFOX/FOLFIRI in Advanced or Metastatic Colorectal Cancer

Efficacy and Safety of Triweekly Cetuximab in Combination With Capecitabine as First-line Maintenance Treatment for KRAS/BRAF Wild-type Metastatic Colorectal Cancer

ctDNA-Guided Cetuximab or Bevacizumab Plus Trifluridine/Tipiracil in RAS/BRAF Wild-Type mCRC

A Safety, Pharmacokinetic and Efficacy Study of NUC-3373 in Combination With Standard Agents Used in Colorectal Cancer Treatment

Trifluridine/Tipiracil Combined With Cetuximab in the Treatment of Third-line and Above RAS/BRAF Wild-type mCRC

Palbociclib With Cetuximab and IMRT for Locally Advanced Squamous Cell Carcinoma

PD 0332991 and Cetuximab in Patients With Incurable SCCHN

Study of Anti-Epidermal Growth Factor Receptor (EGFr) Antibody, Cetuximab, in Combination With Gemcitabine/Carboplatin in Patients With Stage IV Lung Cancer

Efficacy of VIC Regimen in BRAF Mutant Metastatic Colorectal Cancer

Cetuximab and Pembrolizumab in Treating Patients With Colorectal Cancer That is Metastatic or Cannot Be Removed by Surgery

Intraarterial Infusion Of Erbitux and Bevacizumab For Relapsed/Refractory Intracranial Glioma In Patients Under 22

A Phase I/II Study of Radiation Therapy, Paclitaxel Poliglumex and Cetuximab in Advanced Head and Neck Cancer

PI3K Inhibitor BKM120 and Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Everolimus, Cetuximab and Capecitabine in Patients With Metastatic Pancreatic Cancer

IMPACT-CRC

COPAN-ORL06

COMMENCE

Nab-Paclitaxel, Cisplatin, and Cetuximab With Concurrent Radiation Therapy for Locally Advanced Head and Neck Cancer

Cetuximab-IRDye 800CW in Detecting Tumors in Patients With Malignant Glioma Undergoing Surgery

PembroMab

Combination of Cetuximab and NK Immunotherapy for Recurrent Non-small Cell Lung Cancer

THERAPY

NKEXPHNC

RAD001 in Combination With Cetuximab and Cisplatin in Recurrent and Metastatic SCCHN

A Phase 1-2 Trial of Cetuximab in Combination With Oxaliplatin, Capecitabine, and Radiation Therapy Followed by Surgery for Locally-advanced Rectal Cancer

DUCRO-HN

Abraxane in Combination With Carboplatin, Erbitux and IMRT for Locally Advanced Squamous Cancer of the Head and Neck

Cetuximab, Cisplatin and BYL719 for HPV-Associated Oropharyngeal Squamous Cell Carcinoma

EXCITE

Chemoradiation Treatment for Head and Neck Cancer

Erlotinib and Cetuximab in Treating Patients With Advanced Solid Tumors With Emphasis on Non-Small Cell Lung Cancer

SU011248 in Combination With Irinotecan and Cetuximab as a Second Line Regimen for Stage IV Colorectal Cancer

Pemetrexed Plus Cetuximab in Patients With Recurrent Non Small Cell Lung Cancer

Fluorouracil, Cisplatin, Cetuximab, and Radiation Therapy in Treating Patients With Esophageal Cancer That Can Be Removed by Surgery

A Randomised Trial With Irinotecan, Cetuximab and Everolimus (ICE)Compared to Capecitabine and Oxaliplatin (CapOx) for Patients With Gemcitabin Resistant Pancreatic Cancer

Phase I/Randomized Phase II Study of Second Line Therapy With Irinotecan + Cetuximab +/- RAD001 for Colorectal Cancer

Cetuximab in Patients With Lung Adenocarcinoma Receiving Erlotinib That Have Developed "Acquired Resistance" to Erlotinib

Study of Sorafenib/Cetuximab in Head and Neck Cancer

A Study of Carboplatin, Cetuximab and RAD001 in Advanced Head and Neck Cancer

Cetuximab, Oxaliplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Esophageal Cancer

Chemoradiation Plus Weekly c225 Against Locoregionally Advanced Nasopharyngeal Carcinoma (NPC)

ACCEPT

Combination Chemotherapy, Cetuximab and Radiation for Patients With Localized Gastric Cancer